Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey

被引:26
|
作者
Zhou, Yang [1 ]
van den Hof, Susan [2 ,3 ]
Wang, Shengfen [1 ]
Pang, Yu [1 ]
Zhao, Bing [1 ]
Xia, Hui [1 ]
Anthony, Richard [4 ]
Ou, Xichao [1 ]
Li, Qiang [1 ]
Zheng, Yang [1 ]
Song, Yuanyuan [1 ]
Zhao, Yanlin [1 ]
van Soolingen, Dick [4 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
[2] KNCV TB Fdn, The Hague, Netherlands
[3] Amsterdam Med Ctr, Dept Global Hlth, Pietersbergweg 17, Amsterdam, Netherlands
[4] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
LARGE SEQUENCE POLYMORPHISMS; GENETIC DIVERSITY; BEIJING GENOTYPE; EVOLUTION; ORIGIN; CLONE; SUBLINEAGES; PULMONARY; RIFAMPIN; INSIGHTS;
D O I
10.1371/journal.pone.0174197
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We describe the population structure of a representative collection of 3,133 Mycobacterium tuberculosis isolates, collected within the framework of a national resistance survey from 2007 in China. Genotyping data indicate that the epidemic strains in China can be divided into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these strains has spread national wide. The density of Beijing strains is high in the whole of China (average 70%), but the highest prevalence was found North of the Yellow river. The Euro-American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more prevalent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly higher level of resistance to rifampicin (14%, p < 0.001), ethambutol (9%, p = 0.001), and ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the highest cluster rate (28%) and presented a significantly elevated level of resistance to streptomycin (44%, p < 0.001). Our findings suggest that standardised treatment in this region may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-American lineage may have thrived when streptomycin was used without rifampicin for treatment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing lineage appears to be spreading.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Evolution of Mycobacterium tuberculosis drug resistance in the genomic era
    Nimmo, Camus
    Millard, James
    Faulkner, Valwynne
    Monteserin, Johana
    Pugh, Hannah
    Johnson, Eachan Oliver
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [32] Genetic diversity and drug resistance of Mycobacterium tuberculosis in Ecuador
    Zurita, J.
    Espinel, N.
    Barba, P.
    Ortega-Paredes, D.
    Zurita-Salinas, C.
    Rojas, Y.
    Alcocer, I.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (02) : 166 - +
  • [33] DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN DIFFERENT LOCALIZATIONS OF THE DISEASE
    Yablonskii, P. K.
    Vishnevskiy, B., I
    Solovyeva, N. S.
    Manicheva, O. A.
    Dogonadze, M. Z.
    Melnikova, N. N.
    Yu, Zhuravlev V.
    INFEKTSIYA I IMMUNITET, 2016, 6 (02): : 133 - 140
  • [34] Signatures of Selection at Drug Resistance Loci in Mycobacterium tuberculosis
    Mortimer, Tatum D.
    Weber, Alexandra M.
    Pepperell, Caitlin S.
    MSYSTEMS, 2018, 3 (01)
  • [35] Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis
    Abbadi, Said H.
    Sameaa, G. Abdel
    Morlock, G.
    Cooksey, R. C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (06) : 673 - 678
  • [36] A multifaceted interplay between virulence, drug resistance, and the phylogeographic landscape of Mycobacterium tuberculosis
    Mokrousov, Igor
    Vinogradova, Tatiana
    Dogonadze, Marine
    Zabolotnykh, Natalia
    Vyazovaya, Anna
    Vitovskaya, Maria
    Solovieva, Natalia
    Ariel, Boris
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [37] Characterization of Mycobacterium tuberculosis strains in Beijing, China: drug susceptibility phenotypes and Beijing genotype family transmission
    Yi Liu
    Xuxia Zhang
    Yuqing Zhang
    Yong Sun
    Cong Yao
    Wei Wang
    Chuanyou Li
    BMC Infectious Diseases, 18
  • [38] Genetic diversity, evolution and drug resistance of Mycobacterium tuberculosis lineage 2
    Atavliyeva, Sabina
    Auganova, Dana
    Tarlykov, Pavel
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [39] Genetic diversity, population structure and drug resistance of Mycobacterium tuberculosis in Peru
    Taype, C. A.
    Agapito, J. C.
    Accinelli, R. A.
    Espinoza, J. R.
    Godreuil, S.
    Goodman, S. J.
    Banuls, A. L.
    Shaw, M. A.
    INFECTION GENETICS AND EVOLUTION, 2012, 12 (03) : 577 - 585
  • [40] There is no correlation between sublineages and drug resistance of Mycobacterium tuberculosis Beijing/W lineage clinical isolates in Xinjiang, China
    Yuan, L.
    Huang, Y.
    Mi, L. G.
    Li, Y. X.
    Liu, P. Z.
    Zhang, J.
    Liang, H. Y.
    Li, F.
    Li, H.
    Zhang, S. Q.
    Li, W. J.
    EPIDEMIOLOGY AND INFECTION, 2015, 143 (01) : 141 - 149